サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1659352

リアルタイムPCR（qPCR）とデジタルPCR（dPCR）の世界市場

Real-time PCR (qPCR) and Digital PCR (dPCR)

出版日
ページ情報
英文 88 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
リアルタイムPCR（qPCR）とデジタルPCR（dPCR）の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 88 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

リアルタイムPCR（qPCR）とデジタルPCR（dPCR）の世界市場は2030年までに84億米ドルに達する

2024年に59億米ドルと推定されるリアルタイムPCR（qPCR）とデジタルPCR（dPCR）の世界市場は、2024年から2030年にかけてCAGR 6.1%で成長し、2030年には84億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである定量技術は、CAGR 5.7％を記録し、分析期間終了時には76億米ドルに達すると予測されます。デジタル技術セグメントの成長率は、分析期間でCAGR 9.7％と推定されます。

米国市場は16億米ドル、中国はCAGR 9.8%で成長予測

米国のリアルタイムPCR（qPCR）とデジタルPCR（dPCR）市場は2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに19億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と6.4％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

リアルタイムPCR（qPCR）とデジタルPCR（dPCR）：主要動向と促進要因のまとめ

最新の診断におけるリアルタイムPCR（qPCR）とデジタルPCR（dPCR）の違いは何か？

リアルタイムPCR（qPCR）とデジタルPCR（dPCR）は、DNAとRNAの検出と定量において高い精度と感度を提供する分子診断における2つの先進技術であるが、方法論と応用において根本的に異なります。リアルタイムPCRは定量的PCR（qPCR）としても知られ、DNA配列を増幅し、蛍光色素またはプローブを用いて増幅産物の量をリアルタイムでデータ化します。この蛍光により、研究者は各PCRサイクル中のシグナル強度を測定することでDNAターゲットを定量することができ、病原体の定量や遺伝子発現解析などのアプリケーションに非常に有用です。対照的に、デジタルPCR（dPCR）は新しい方法で、DNAサンプルを何千もの小さな個々の反応に分割し、各分割がDNA標的を含むか含まないかを可能にします。増幅後、dPCRは蛍光が陽性であるパーティションをカウントし、qPCRで必要とされる標準曲線を必要としない正確な絶対定量を提供します。

dPCRの絶対定量能力は、腫瘍学における低レベル変異の検出や慢性感染症におけるウイルス量の評価など、高い精度を必要とするアプリケーションに理想的です。一方、qPCRはそのスケーラビリティ、効率性、確立されたプロトコールにより、特に相対定量で十分なルーチン診断において広く普及しています。両技術はそれぞれ異なる目的を果たすが、診断においては互いに補完し合うことが多く、ウイルス学、腫瘍学、遺伝学などの多様な研究分野において、DNAを顕著な精度で検出、測定、解析するツールを提供します。

qPCRとdPCRはどのように疾患検出とゲノミクスの進歩を促進しているのか？

qPCRとdPCRは、感染症診断、がん研究、出生前スクリーニングなどに応用され、疾患の検出とゲノミクスにおいて極めて重要な役割を果たしています。例えば、COVID-19パンデミックの際、qPCRはSARS-CoV-2感染を検出するための大量検査に役立ち、公衆衛生当局がウイルスの拡散を監視できるようになりました。同様に、腫瘍学では、qPCRは腫瘍マーカーの測定や治療効果のモニタリングに役立っており、その迅速なターンアラウンドタイムは有益です。一方、希少な遺伝子事象を高感度で定量化できるdPCRの能力は、低頻度の突然変異の検出において非常に有用であり、特に少量の血液サンプルから循環腫瘍DNAを検出しなければならないリキッドバイオプシーにおいて有用です。

ゲノミクス研究では、dPCRの正確な定量化により、遺伝子編集や遺伝子治療に新たな可能性が生まれました。遺伝子コピーの正確な定量化や希少な遺伝子変異の検出は、研究の質や治療効果にとって極めて重要です。さらに、dPCRは非侵襲的な出生前検査を進歩させ、母体の血液から胎児のDNAを正確に検出することを可能にし、侵襲的な処置の必要性を減らしています。この超高感度技術は、がんの微小残存病変のモニタリングにおいても非常に貴重であり、治療後に微量の腫瘍DNAでも検出することができるため、再発の早期警告を与えることができます。qPCRとdPCRはどちらもゲノム研究に幅広く貢献し、希少遺伝性疾患、エピジェネティクス研究、薬理ゲノミクスの発見を可能にします。

qPCRとdPCRの能力を拡大する技術的進歩とは？

自動化、多重化、およびデータ解析における革新は、qPCRおよびdPCRが達成できることの限界を押し広げ、より高速で汎用性が高く、大規模なアプリケーションに適しています。自動化によってqPCRとdPCRのワークフローが合理化され、臨床診断や大規模な研究で重要な、より大量のサンプルを最小限の手作業で処理できるようになった。複数のDNA標的を1回の反応で検出するマルチプレキシングにより、qPCRとdPCRの両方で検査効率が大幅に向上し、研究者は複数の遺伝子や病原体を同時に分析できるようになりました。このマルチプレキシング機能は、感染症検査や腫瘍学など、効果的な治療計画を立てるために包括的なスクリーニングが不可欠な分野で特に有用です。

小型化と携帯型PCR装置により、qPCRとdPCRをポイントオブケア検査やフィールドベースの診断に応用できるようになり、アクセス性がさらに向上しました。例えば、ハンドヘルド機器により、遠隔地や患者のベッドサイドで迅速な分子検査を実施することが可能になり、これは救急医療や地方のヘルスケア環境におけるタイムリーな診断に不可欠です。ソフトウェアとデータ解析の改善もPCRデータの解釈を一変させ、人工知能と機械学習アルゴリズムが結果の最適化、パターンの特定、遺伝病や感染症に対するより深い洞察の提供に役立っています。PCR技術におけるこれらの進歩は、より広範な診断アプリケーション、より迅速な応答時間、より高い感度を可能にし、qPCRとdPCRを分子診断とゲノム研究の進化するニーズに適応可能にしています。

リアルタイムPCR（qPCR）とデジタルPCR（dPCR）市場の成長の原動力は？

qPCRおよびdPCR市場の成長の原動力は、精密診断に対する需要の高まり、技術の進歩、個別化医療への注目の高まりです。COVID-19検査における極めて重要な役割に見られるように、感染症との闘いにおけるqPCRおよびdPCRの重要性は、迅速で正確な診断に対する世界のニーズを浮き彫りにし、市場の拡大に拍車をかけています。腫瘍学では、個人の遺伝子プロファイルに基づいて治療法を調整する精密医療の台頭により、変異を検出し治療反応をモニターするためのqPCRやdPCRのような高精度で定量可能なツールに対する需要が高まっています。さらに、dPCRの絶対的な定量能力は、希少な変異や低レベルの病原体の検出に不可欠であり、リキッドバイオプシーや早期がんの検出などのアプリケーションで必要とされています。

これと並行して、自動化、小型化、多重化を含むPCR技術の革新は、qPCRとdPCRをより身近で効率的なものにし、臨床診断、環境モニタリング、農業バイオテクノロジーへの応用を広げています。遺伝子研究、特に遺伝子治療とゲノム編集の急速な成長により、研究者が遺伝子改変の結果を評価するために正確な測定を必要とするため、dPCRの需要も増加しています。さらに、ヘルスケアプロバイダーと消費者が同様に、より非侵襲的な診断方法を推進する中、qPCRとdPCRは、出生前スクリーニングや早期がん検出のような非侵襲的な検査に信頼性の高いソリューションを提供し、人気が高まり続けています。これらの動向を総合すると、精密診断、個別化治療、最新のゲノム解析においてqPCRとdPCRの役割が拡大していることが明らかになり、これらの技術はヘルスケアとバイオテクノロジーの将来における礎石として位置付けられています。

セグメント

技術（定量、デジタル）、製品タイプ（消耗品・試薬、装置、ソフトウェア・サービス）、アプリケーション（調査、臨床、その他アプリケーション）

調査対象企業の例（全32社）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems
  • Biomeme Inc.
  • Biomerieux S.A.
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Cole-Parmer Instrument Company Llc
  • Danaher Corporation
  • Elitech Group Sas
  • Enzo Life Sciences, Inc.
  • Eppendorf AG
  • F. Hoffman-La Roche Ltd.
  • Fluidigm Corporation
  • JN Medsys
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quanta Biosciences Inc.
  • Sacace Biotechnologies Srl
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22687

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market to Reach US$8.4 Billion by 2030

The global market for Real-time PCR (qPCR) and Digital PCR (dPCR) estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Digital Technology segment is estimated at 9.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.8% CAGR

The Real-time PCR (qPCR) and Digital PCR (dPCR) market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Real-Time PCR (qPCR) and Digital PCR (dPCR): Key Trends & Drivers Summarized

What Distinguishes Real-Time PCR (qPCR) from Digital PCR (dPCR) in Modern Diagnostics?

Real-time PCR (qPCR) and digital PCR (dPCR) are two advanced techniques in molecular diagnostics that offer high accuracy and sensitivity in detecting and quantifying DNA and RNA, yet they differ fundamentally in methodology and applications. Real-time PCR, also known as quantitative PCR (qPCR), amplifies DNA sequences and provides real-time data on the quantity of amplified product using fluorescent dyes or probes. This fluorescence allows researchers to quantify the DNA target by measuring signal intensity during each PCR cycle, making it highly useful in applications like pathogen quantification and gene expression analysis. In contrast, digital PCR (dPCR) is a newer method that partitions a DNA sample into thousands of tiny individual reactions, allowing each partition to either contain or not contain the DNA target. Following amplification, dPCR counts the partitions with positive fluorescence, offering precise, absolute quantification without the need for a standard curve, as required in qPCR.

The absolute quantification capability of dPCR makes it ideal for applications needing high precision, such as detecting low-level mutations in oncology or assessing viral loads in chronic infections. Meanwhile, qPCR remains widely popular due to its scalability, efficiency, and established protocols, particularly in routine diagnostics, where relative quantification is sufficient. Both technologies serve distinct purposes but often complement each other in diagnostics, offering tools to detect, measure, and analyze DNA with remarkable accuracy across diverse research areas, including virology, oncology, and genetics.

How Are qPCR and dPCR Driving Advances in Disease Detection and Genomics?

qPCR and dPCR are pivotal in disease detection and genomics, with applications spanning infectious disease diagnostics, cancer research, prenatal screening, and more. qPCR is especially valuable in infectious disease testing, where its rapid, quantitative capabilities enable timely diagnosis and management of pathogen loads. For example, during the COVID-19 pandemic, qPCR was instrumental in mass testing to detect SARS-CoV-2 infections, allowing public health authorities to monitor virus spread. Similarly, in oncology, qPCR assists in measuring tumor markers and monitoring treatment efficacy, where its fast turnaround time is beneficial. Meanwhile, dPCR’s ability to quantify rare genetic events with high sensitivity has made it invaluable in detecting low-frequency mutations, particularly useful in liquid biopsies, where circulating tumor DNA must be detected from a small blood sample.

In genomics research, dPCR’s precise quantification has opened new possibilities for gene editing and gene therapy, where accurately quantifying gene copies or detecting rare genetic variants is critical for research quality and therapeutic efficacy. Additionally, dPCR is advancing non-invasive prenatal testing, allowing for accurate detection of fetal DNA from maternal blood, reducing the need for invasive procedures. This ultra-sensitive technology is also invaluable in monitoring minimal residual disease in cancer, where even a trace amount of tumor DNA can be detected post-treatment, providing early warning signs of recurrence. Both qPCR and dPCR contribute extensively to genomic studies, enabling discoveries in rare genetic disorders, epigenetic research, and pharmacogenomics, thus driving precision medicine forward with accurate and actionable data.

What Technological Advancements Are Expanding qPCR and dPCR Capabilities?

Innovations in automation, multiplexing, and data analysis are pushing the boundaries of what qPCR and dPCR can achieve, making them faster, more versatile, and suitable for larger-scale applications. Automation has streamlined qPCR and dPCR workflows, allowing laboratories to handle higher sample volumes with minimal manual input, critical in clinical diagnostics and large-scale studies. Multiplexing, where multiple DNA targets are detected within a single reaction, has significantly improved testing efficiency in both qPCR and dPCR, enabling researchers to analyze multiple genes or pathogens simultaneously. This multiplexing capability is particularly valuable in fields like infectious disease testing and oncology, where comprehensive screening is essential for effective treatment planning.

Miniaturization and portable PCR devices have further enhanced accessibility, allowing qPCR and dPCR to be applied in point-of-care testing and field-based diagnostics. For example, handheld devices now make it possible to conduct rapid molecular testing in remote areas or at a patient’s bedside, which is essential for timely diagnostics in emergency and rural healthcare settings. Improvements in software and data analytics have also transformed PCR data interpretation, with artificial intelligence and machine learning algorithms helping to optimize results, identify patterns, and provide deeper insights into genetic and infectious diseases. These advancements in PCR technology enable broader diagnostic applications, faster response times, and greater sensitivity, making qPCR and dPCR adaptable to the evolving needs of molecular diagnostics and genomic research.

What Is Driving Growth in the Real-Time PCR (qPCR) and Digital PCR (dPCR) Market?

The growth in the qPCR and dPCR market is driven by increasing demand for precision diagnostics, technological advancements, and a rising focus on personalized medicine. qPCR and dPCR’s importance in the fight against infectious diseases, as evidenced by their pivotal role in COVID-19 testing, has highlighted the need for fast, accurate diagnostics worldwide, fueling market expansion. In oncology, the rise of precision medicine—where treatments are tailored based on individual genetic profiles—has spurred demand for highly accurate, quantifiable tools like qPCR and dPCR to detect mutations and monitor treatment responses. Additionally, dPCR’s absolute quantification capability makes it indispensable in detecting rare mutations or low-level pathogens, a necessity in applications like liquid biopsy and early-stage cancer detection.

In parallel, innovations in PCR technology, including automation, miniaturization, and multiplexing, are making qPCR and dPCR more accessible and efficient, broadening their applications in clinical diagnostics, environmental monitoring, and agricultural biotechnology. The rapid growth in genetic research, particularly in gene therapy and genome editing, has also increased demand for dPCR as researchers need precise measurements to assess gene modification outcomes. Furthermore, as healthcare providers and consumers alike push for more non-invasive diagnostic methods, qPCR and dPCR continue to grow in popularity, offering reliable solutions for non-invasive tests like prenatal screening and early cancer detection. Collectively, these trends underline the expanding role of qPCR and dPCR in precision diagnostics, personalized treatment, and modern genomics, positioning these technologies as cornerstones in the future of healthcare and biotechnology.

SCOPE OF STUDY:

The report analyzes the Real-time PCR (qPCR) and Digital PCR (dPCR) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Quantitative, Digital); Product Type (Consumables & Reagents, Instruments, Software & Services); Application (Research, Clinical, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems
  • Biomeme Inc.
  • Biomerieux S.A.
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Cole-Parmer Instrument Company Llc
  • Danaher Corporation
  • Elitech Group Sas
  • Enzo Life Sciences, Inc.
  • Eppendorf AG
  • F. Hoffman-La Roche Ltd.
  • Fluidigm Corporation
  • JN Medsys
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quanta Biosciences Inc.
  • Sacace Biotechnologies Srl
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Real-time PCR (qPCR) and Digital PCR (dPCR) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Precision Diagnostics Drives Adoption of Real-Time PCR (qPCR) and Digital PCR (dPCR) in Clinical Testing
    • Rising Prevalence of Infectious Diseases Spurs Use of qPCR and dPCR for Rapid and Accurate Pathogen Detection
    • Expansion of Genetic Research and Genomic Studies Propels Demand for qPCR and dPCR in Molecular Biology Labs
    • Increasing Focus on Cancer Research Boosts Adoption of dPCR for High-Sensitivity Mutation Detection and Liquid Biopsy Applications
    • Technological Advancements in PCR Instrumentation Improve Accuracy and Speed of qPCR and dPCR Testing
    • Growing Use of qPCR and dPCR in Agricultural Biotechnology Expands Market for Crop and Livestock Genetic Testing
    • Rising Demand for Companion Diagnostics in Personalized Medicine Drives Market for qPCR and dPCR in Targeted Therapy
    • Increasing Need for Rapid COVID-19 and Other Viral Testing Enhances Adoption of qPCR as a Gold Standard
    • Development of Multiplex PCR Techniques Expands Application Scope for qPCR and dPCR in Multi-Target Testing
    • Adoption of qPCR and dPCR in Environmental Monitoring Strengthens Market for Pollution and Water Quality Testing
    • Rising Awareness of Antimicrobial Resistance Spurs Use of qPCR and dPCR in Antibiotic Resistance Monitoring
    • Increased Use of qPCR and dPCR in Food Safety Testing Expands Market for Pathogen and Allergen Detection in Food Products
    • Growing Focus on Biomarker Discovery for Chronic Diseases Boosts Adoption of qPCR and dPCR in Diagnostic Research
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Real-time PCR (qPCR) and Digital PCR (dPCR) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Quantitative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Quantitative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Quantitative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Digital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION